Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BCX4208 Dose-Ranging Study in Gout
NCT00985127Phase 2Completed
- Sponsor
- BioCryst Pharmaceuticals, Inc.
- Start
- Sep 2009
- Primary completion
- Sep 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Ulodesine in gout, sponsored by BioCryst Pharmaceuticals, Inc.. Started Sep 2009; status: completed.
02
Drugs
Ulodesine
03
Conditions
gout
Beyond the preview
Go deeper on NCT00985127.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00985127.